About this trial
The purpose of this post-market study is to generate post-market, real- world evidence on the safety and performance of COAPTIUM® CONNECT with TISSIUM® LIGHT for the atraumatic sutureless repair of acute digital (sensory) injuries of the hand in adults through prospective data collection, to confirm safety and performance of the device.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subjects aged 18 years or older at the time of signing the informed consent form.
Digital sensory nerve with associated tendon injury, OR
Digital sensory nerve without tendon injury.
Nerve must be completely transected and appropriate for primary repair.
Disqualifiers
Known or suspected hypersensitivity to any constituents of the product, including the polymer (Aminated polyglycerol sebacate acrylate) or the additive FD&C Blue No. 1 Dye (brilliant blue FCF);
Known diagnosis of peripheral neuropathy;
Any injury requiring revascularization due to critical ischemia from damage to the blood vessels;
Subject's traumatic lesion is older than 14 days at the time of surgery;
Trial design
Single group
Treatments tested in this trial
COAPTIUM® CONNECT
DeviceCOAPTIUM® CONNECT with TISSIUM® LIGHT is indicated for the sutureless repair of peripheral nerve injuries not in continuity in which a gap closure ≤ 1 cm is present or can be achieved with flexion of the extremity.
Treatment groups
Trial outcomes
Primary outcomes
Sensory Recovery at 6-Months
Rate of higher threshold meaningful recovery (HTMR) at 6 months post-surgery
Secondary outcomes
Sensory Recovery at 12-Months
Rate of higher threshold meaningful recovery (HTMR) at 12 months post-surgery
Locations
This trial is not recruiting at the moment. You can still explore other options: